BACKGROUND: Impaired kidney function is associated with increased risk for cardiovascular events. We evaluated whether kidney function is associated with atrial fibrillation (AF) risk in elderly persons. METHODS AND RESULTS: Subjects were participants in the Cardiovascular Health Study (CHS), a population-based cohort of ambulatory elderly. Measures of kidney function were cystatin C and creatinine-based estimated glomerular filtration rate (eGFR). Among the 4663 participants, 342 (7%) had AF at baseline and 579 (13%) developed incident AF during follow-up (mean 7.4 years). In unadjusted analyses, cystatin C quartiles were strongly associated with prevalent AF with a nearly 3-fold odds in the highest quartile compared with the lowest (HR=1.19, 95% CI [0.80-1.76] in quartile 2; HR=2.00, 95% CI [1.38-2.88] in quartile 3; and HR=2.87, 95% CI [2.03-4.07] in quartile 4). This increased risk for prevalent AF remained significant after multivariate adjustment. The risk for incident AF increased across cystatin C quartiles in the unadjusted analysis (HR=1.37, 95% CI [1.07-1.75] in quartile 2; HR=1.43, 95% CI [1.11-1.84] in quartile 3; and HR=1.88, 95% CI [1.47-2.41] in quartile 4); however, after multivariate adjustment, these findings were no longer significant. An estimated GFR <60 mL.min.1.73m(2) was associated with prevalent and incident AF in unadjusted, but not multivariate analyses. CONCLUSIONS: Impaired kidney function, as measured by cystatin C, is an independent marker of prevalent AF; however, neither cystatin C nor eGFR are predictors of incident AF.
BACKGROUND:Impaired kidney function is associated with increased risk for cardiovascular events. We evaluated whether kidney function is associated with atrial fibrillation (AF) risk in elderly persons. METHODS AND RESULTS: Subjects were participants in the Cardiovascular Health Study (CHS), a population-based cohort of ambulatory elderly. Measures of kidney function were cystatin C and creatinine-based estimated glomerular filtration rate (eGFR). Among the 4663 participants, 342 (7%) had AF at baseline and 579 (13%) developed incident AF during follow-up (mean 7.4 years). In unadjusted analyses, cystatin C quartiles were strongly associated with prevalent AF with a nearly 3-fold odds in the highest quartile compared with the lowest (HR=1.19, 95% CI [0.80-1.76] in quartile 2; HR=2.00, 95% CI [1.38-2.88] in quartile 3; and HR=2.87, 95% CI [2.03-4.07] in quartile 4). This increased risk for prevalent AF remained significant after multivariate adjustment. The risk for incident AF increased across cystatin C quartiles in the unadjusted analysis (HR=1.37, 95% CI [1.07-1.75] in quartile 2; HR=1.43, 95% CI [1.11-1.84] in quartile 3; and HR=1.88, 95% CI [1.47-2.41] in quartile 4); however, after multivariate adjustment, these findings were no longer significant. An estimated GFR <60 mL.min.1.73m(2) was associated with prevalent and incident AF in unadjusted, but not multivariate analyses. CONCLUSIONS:Impaired kidney function, as measured by cystatin C, is an independent marker of prevalent AF; however, neither cystatin C nor eGFR are predictors of incident AF.
Authors: Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Alvaro Alonso; Faye L Lopez; Kunihiro Matsushita; Laura R Loehr; Sunil K Agarwal; Lin Y Chen; Elsayed Z Soliman; Brad C Astor; Josef Coresh Journal: Circulation Date: 2011-06-06 Impact factor: 29.690
Authors: Roopinder K Sandhu; Tobias Kurth; David Conen; Nancy R Cook; Paul M Ridker; Christine M Albert Journal: Am J Cardiol Date: 2011-11-17 Impact factor: 2.778
Authors: Jouni Karppi; Sudhir Kurl; Timo Heikki Mäkikallio; Kimmo Ronkainen; Jari Antero Laukkanen Journal: Eur J Epidemiol Date: 2012-12-13 Impact factor: 8.082
Authors: Anna C van der Burgh; Sven Geurts; M Arfan Ikram; Ewout J Hoorn; Maryam Kavousi; Layal Chaker Journal: J Am Heart Assoc Date: 2022-05-17 Impact factor: 6.106
Authors: Linzi Li; Elizabeth Selvin; Pamela L Lutsey; Ron C Hoogeveen; Wesley T O'Neal; Elsayed Z Soliman; Lin Y Chen; Alvaro Alonso Journal: Am Heart J Date: 2018-08-10 Impact factor: 4.749
Authors: Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert Journal: Clin J Am Soc Nephrol Date: 2017-08-10 Impact factor: 8.237
Authors: Esther D Kim; Elsayed Z Soliman; Josef Coresh; Kunihiro Matsushita; Lin Yee Chen Journal: J Am Soc Nephrol Date: 2021-01-28 Impact factor: 10.121
Authors: Roopinder K Sandhu; David Conen; Usha B Tedrow; Kathryn C Fitzgerald; Aruna D Pradhan; Paul M Ridker; Robert J Glynn; Christine M Albert Journal: J Am Heart Assoc Date: 2014-05-01 Impact factor: 5.501
Authors: Richard L Amdur; Monica Mukherjee; Alan Go; Ian R Barrows; Ali Ramezani; Jun Shoji; Muredach P Reilly; Joseph Gnanaraj; Raj Deo; Sylvia Roas; Martin Keane; Steve Master; Valerie Teal; Elsayed Z Soliman; Peter Yang; Harold Feldman; John W Kusek; Cynthia M Tracy; Dominic S Raj Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240
Authors: Chang Hee Kwon; Jun Kim; Min Su Kim; Jae-Hyung Roh; Jin Hee Choi; Uk Jo; Woo Seok Lee; Yoo Ri Kim; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim Journal: Korean Circ J Date: 2015-11-25 Impact factor: 3.243